Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback